¼¼°èÀÇ Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀå(2025³â)
Contrast Media Injectors Global Market Report 2025
»óǰÄÚµå : 1667645
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 200 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,301,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,108,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,914,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀå ±Ô¸ð´Â ÇâÈÄ ¼ö³â°£ °­·ÂÇÏ°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2029³â 25¾ï 3,000¸¸ ´Þ·¯¿¡ À̸£°í, CAGR·Î 9.1%ÀÇ ¼ºÀåÀÌ Àü¸ÁµË´Ï´Ù. ¿¹Ãø±â°£ÀÇ ¼ºÀåÀº ÀÎÅͺ¥¼Å³Î ¶óµð¿Ã·ÎÁö ¼ö¼ú Áõ°¡, ¾ÏÀÇ À¯º´·ü Áõ°¡, ȯÀÚÀÇ ¾ÈÀü¼º°ú ÄèÀû¼ºÀÇ Áß½Ã, ÀÇ·á ¼­ºñ½ºÀÇ ¼¼°èÈ­, ±ÔÁ¦ Áö¿ø°ú ÄÄÇöóÀ̾𽺿¡ ÀÇÇÑ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹Ãø±â°£ÀÇ ÁÖ¿ä µ¿ÇâÀº ÀÚµ¿È­¿Í ¿¬°á¼º, µà¾óÇìµå ÁÖÀÔ±âÀÇ µîÀå, ÁÖÀԱ⠱â¼úÀÇ Áøº¸, ȯÀÚÀÇ ¾ÈÀü¼ºÀÇ Áß½Ã, ÀÎÅͺ¥¼Å³Î ¶óµð¿Ã·ÎÁö ¼ö¼ú Áõ°¡, À̹Ì¡ ±â¼ú°ú ¸ð´Þ¸®Æ¼ÀÇ °­È­ µîÀÔ´Ï´Ù.

Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀåÀÇ ¼ºÀåÀº ¾Ï°ú ½ÉÇ÷°ü Áúȯ(CVD)ÀÇ ÀÌȯÀ² Áõ°¡·Î ÃßÁøµÉ Àü¸ÁÀÔ´Ï´Ù. ÅëÁ¦ ºÒ°¡´ÉÇÑ ¼¼Æ÷ Áõ½Ä°ú È®»êÀ» Ư¡À¸·Î ÇÏ´Â ¾Ï°ú ½ÉÇ÷°ü¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â CVD´Â ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎÀÔ´Ï´Ù. Á¶¿µÁ¦ ÁÖÀÔ±â´Â ¿µ»ó Áø´Ü¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϸç, È­Áú Çâ»ó, ȯÀÚ ¾ÈÀü º¸Àå, Ç÷·ù ¹× Á¶Á÷ °ü·ù °³¼±¿¡ ±â¿©ÇÕ´Ï´Ù. ƯÈ÷ American Cancer SocietyÀÇ Åë°è¿¡ µû¸£¸é ¾Ï ȯÀÚ¼ö´Â 2021³â 189¸¸ 8,160¸í¿¡¼­ 2023³â 1¿ù 195¸¸ 8,310¸íÀ¸·Î 3.16% Áõ°¡ÇÑ °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. ¶ÇÇÑ World Heart FederationÀÇ º¸°í¼­¿¡ µû¸£¸é 2023³â 4¿ù¿¡´Â ¼¼°è¿¡¼­ 5¾ï ¸íÀÌ ³Ñ´Â ½ÉÇ÷°ü ÁúȯÀ» ¾Î°í ÀÖÀ¸¸ç, 2021³â »ç¸ÁÀÚ ¼ö´Â 2,050¸¸ ¸í¿¡ À̸£·¶À¸¸ç, ¼¼°è ÃÑ »ç¸ÁÀÚ ¼öÀÇ °ÅÀÇ 3ºÐÀÇ 1À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¾ÏÀ̳ª CVD ȯÀÚÀÇ ±ÞÁõÀº Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀåÀÇ Å« ÃËÁø¿äÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù.

ºñħ½ÀÀû Áø´Ü ÀýÂ÷¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ¹Ì·¡¿¡ Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ºñħ½ÀÀû Áø´Ü ÀýÂ÷´Â ÀÚ¿¬Àû ¶Ç´Â ÀΰøÀûÀÎ °³±¸ºÎ·ÎºÎÅÍ ½Åü·ÎÀÇ ¹°¸®Àû ÁøÀÔÀ» ÇÊ¿ä·Î ÇÏÁö ¾Ê°Å³ª ÇǺΠħÅõ¸¦ ¼ö¹ÝÇÏ´Â ÀÇ·á °Ë»ç ¶Ç´Â Ä¡·áÀÔ´Ï´Ù. Á¶¿µÁ¦ ÁÖÀÔ±â´Â ºñħ½ÀÀû Áø´Ü¹ý, ƯÈ÷ CT ½ºÄµ ¹× MRI¿Í °°Àº ¿µ»ó Áø´Ü¹ý¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 5¿ù, National Health Service(NHS) England¿¡ µû¸£¸é, 2023³â 1¿ù °¡Àå ÀÚÁÖ »ç¿ëµÇ´Â ¿µ»ó ±â¼úÀº ´Ü¼ø X¼± ÃÔ¿µÀ¸·Î 165¸¸°ÇÀÇ ¼ö¼úÀÌ ÀÌ·ç¾îÁ³½À´Ï´Ù. À̾î ÃÊÀ½ÆÄ Áø´Ü¹ýÀÌ 81¸¸ °Ç, CT ½ºÄµÀÌ 52¸¸ °Ç, MRI°¡ 31¸¸ °ÇÀ̾ú½À´Ï´Ù. µû¶ó¼­ ºñħ½ÀÀû Áø´Ü ÀýÂ÷¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀåÀÇ ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ¼¼°è Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀå¿¡ ´ëÇÑ Á¶»ç ºÐ¼®À» ÅëÇØ ½ÃÀå Æ¯Â¡, ½ÃÀå µ¿Çâ ¹× Àü·«, °¢ Áö¿ª ºÐ¼®, °æÀï ±¸µµ µî¿¡ ´ëÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀå Æ¯Â¡

Á¦3Àå Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀå - ½ÃÀå¿¡ ´ëÇÑ ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, COVID¿Í ȸº¹ÀÇ ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ Á¶¿µÁ¦ ÁÖÀÔ±âÀÇ ¼ºÀå ºÐ¼®, Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀåÀÇ ¼¼ºÐÈ­

Á¦7Àå Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀåÀÇ Áö¿ª°ú ±¹°¡ ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀå

Á¦9Àå Áß±¹ÀÇ Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀå

Á¦10Àå ÀεµÀÇ Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀå

Á¦11Àå ÀϺ»ÀÇ Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀå

Á¦12Àå È£ÁÖ Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀå

Á¦13Àå Àεµ³×½Ã¾ÆÀÇ Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀå

Á¦14Àå Çѱ¹ÀÇ Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀå

Á¦15Àå ¼­À¯·´ÀÇ Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀå

Á¦16Àå ¿µ±¹ Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀå

Á¦17Àå µ¶ÀÏÀÇ Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀå

Á¦18Àå ÇÁ¶û½ºÀÇ Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀå

Á¦19Àå ÀÌÅ»¸®¾ÆÀÇ Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀå

Á¦20Àå ½ºÆäÀÎ Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀå

Á¦21Àå µ¿À¯·´ Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀå

Á¦22Àå ·¯½Ã¾Æ Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀå

Á¦23Àå ºÏ¹ÌÀÇ Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀå

Á¦24Àå ¹Ì±¹ÀÇ Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀå

Á¦25Àå ij³ª´Ù Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀå

Á¦26Àå ³²¹ÌÀÇ Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀå

Á¦27Àå ºê¶óÁú Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀå

Á¦28Àå Áßµ¿ Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀå

Á¦30Àå Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀå °æÀï ±¸µµ¿Í ±â¾÷ ÇÁ·ÎÆÄÀÏ

Á¦31Àå Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀåÀÇ ´Ù¸¥ ÁÖ¿ä ±â¾÷°ú Çõ½ÅÀû ±â¾÷

Á¦32Àå ¼¼°è Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀå °æÀï º¥Ä¡¸¶Å· ¹× ´ë½Ãº¸µå

Á¦33Àå Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀå¿¡¼­ÀÇ ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀåÀÇ ÃÖ±Ù ¹ßÀü

Á¦35Àå Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀåÀÇ ÀáÀ缺ÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

JHS
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Contrast media injectors are advanced medical devices designed for administering contrast media to enhance tissue visibility in medical imaging procedures, ensuring superior accuracy and precision for optimal surgical outcomes.

The primary offerings in the contrast media injectors market include consumables, injector systems, and accessories. Consumables, also known as medical injectors, play a pivotal role in safeguarding against breaks or leaks that could lead to potential harm, injector downtime, or other undesirable incidents. These injectors are integral for conducting safe and consumable imaging procedures in diagnostics. The market features various types of injectors, including single head injectors, dual-head injectors, and syringeless injectors, tailored for applications in radiology, interventional cardiology, and interventional radiology. They find widespread usage in hospitals, diagnostics centers, and ambulatory surgery centers, catering to the diverse needs of medical professionals and contributing to the advancement of imaging precision and diagnostic capabilities.

The contrast media injectors market research report is one of a series of new reports from The Business Research Company that provides contrast media injectors market statistics, including contrast media injectors industry global market size, regional shares, competitors with a contrast media injectors market share, detailed contrast media injectors market segments, market trends and opportunities, and any further data you may need to thrive in the contrast media injectors industry. This contrast media injectors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The contrast media injectors market size has grown strongly in recent years. It will grow from$1.68 billion in 2024 to $1.79 billion in 2025 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to increased incidence of chronic diseases, increased diagnostic imaging procedures, demand for minimally invasive procedures, expansion of healthcare infrastructure, growing aging population

The contrast media injectors market size is expected to see strong growth in the next few years. It will grow to $2.53 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to rise in interventional radiology procedures, increasing prevalence of cancer, focus on patient safety and comfort, globalization of healthcare services, regulatory support and compliance. Major trends in the forecast period include automation and connectivity, emergence of dual-head injectors, advancements in injector technology, focus on patient safety, rise in interventional radiology procedures, enhanced imaging techniques and modalities.

The anticipated growth of the contrast media injectors market is set to be propelled by the increasing incidence of cancer and cardiovascular diseases (CVD). Cancer, characterized by uncontrolled cell growth and dissemination, and CVD, impacting the heart or blood vessels, are driving factors for the market. Contrast media injectors play a crucial role in diagnostic imaging, enhancing image quality, ensuring patient safety, and improving blood flow and tissue perfusion. Notably, statistics from the American Cancer Society reveal a 3.16% growth in cancer cases from 1,898,160 in 2021 to 1,958,310 in January 2023. Additionally, the World Heart Federation reports that over 500 million individuals globally will be affected by cardiovascular diseases in April 2023, leading to 20.5 million fatalities in 2021, constituting nearly one-third of total global mortality. This surge in cancer and CVD cases is a significant driver for the contrast media injectors market.

The increasing demand for non-invasive diagnostic procedures is anticipated to drive the growth of the contrast media injectors market in the future. Non-invasive diagnostic procedures are medical examinations or treatments that do not require physical entry into the body through natural or artificial openings or involve skin penetration. Contrast media injectors play a crucial role in non-invasive diagnostic methods, particularly in imaging techniques such as computed tomography (CT) scans and magnetic resonance imaging (MRI). For example, in May 2023, the National Health Service (NHS) England reported that in January 2023, plain radiography (X-ray) was the most frequently used imaging technique, with 1.65 million procedures performed. This was followed by diagnostic ultrasonography (Ultrasound) at 0.81 million, computerized axial tomography (CT scan) at 0.52 million, and magnetic resonance imaging (MRI) at 0.31 million. Therefore, the growing demand for non-invasive diagnostic procedures is propelling the growth of the contrast media injectors market.

Strategic partnerships are emerging as a prominent trend within the contrast media injectors market. Major companies in this sector are actively engaging in collaborations to foster new relationships, particularly those involving similar product developments. An illustrative example is the collaboration between Qaelum NV, a Belgium-based provider of advanced dose and contrast management software solutions, and Ulrich GmbH & Company KG, a France-based surgical instruments manufacturer and distributor. By pooling their resources, these companies aim to integrate Qaelum NV's advanced contrast management solution with Ulrich Medical's contrast media injectors, thereby addressing the requirements of hospitals and imaging networks. This partnership model demonstrates the industry's commitment to enhancing collaborative efforts for mutual benefit.

Key players in the contrast media injector market are directing their efforts towards the development of innovative products, such as generic contrast media injectables. These pharmaceutical products, containing contrast agents, play a pivotal role in enhancing visibility during medical imaging procedures such as CT scans and MRIs. Notably, Fresenius Kabi, a Germany-based pharmaceutical company, introduced two novel drugs in August 2023. The first, Gadobutrol Injection, is a gadolinium-based contrast agent tailored for MRI use, expanding Fresenius Kabi's radiology portfolio. The second, Plerixafor Injection, serves as a hematopoietic stem cell mobilizer, complementing the company's extensive collection of generic injectable oncology medicines. This strategic focus on product innovation underscores the industry's commitment to gaining a competitive edge and broadening its customer base.

In November 2022, GE HealthCare Technologies Inc., a prominent US-based manufacturing company, entered into a partnership with Ulrich GmbH & Co. KG. The primary objective of this collaboration is to introduce multi-dose contrast media injectors in the U.S. market and bolster the sales of CT motion injectors. Ulrich GmbH & Co. KG., based in France, specializes in the development, production, and distribution of spinal systems and contrast medium injectors. This collaboration exemplifies GE HealthCare Technologies Inc.'s strategic approach to expanding its market presence and leveraging the expertise of partners to enhance its product offerings, particularly in the realm of contrast media injectors.

Major companies operating in the contrast media injectors market include The Bracco Group, Bayer AG, Medtron AG, Ulrich GmbH And Co. KG, General Electric Company, Nemoto Kyorindo Co. Ltd., Guerbet Group, Sino Medical-Device Technology Co. Ltd, Apollo RT Co.Ltd, Shenzhen Anke High-tech Co. Ltd, Vivid Imaging, AngioDynamics. Inc., Medrad Inc., TaeWoong Medical Co. Ltd., Medtronic Plc, ACIST Medical Systems, Boston Scientific Corporation, Mallinckrodt Pharmaceuticals, Lantheus Medical Imaging Inc., Imaxeon Pty Ltd.

North America was the largest region in the contrast media injectors market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global contrast media injectors market report during the forecast period. The regions covered in the contrast media injectors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the contrast media injectors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The contrast media injectors market consists of sales of empower CTA+, hydraulic-powered MR injectors, computed tomography (CT) injectors, and syringe devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Contrast Media Injectors Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on contrast media injectors market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for contrast media injectors ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The contrast media injectors market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Contrast Media Injectors Market Characteristics

3. Contrast Media Injectors Market Trends And Strategies

4. Contrast Media Injectors Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Contrast Media Injectors Growth Analysis And Strategic Analysis Framework

6. Contrast Media Injectors Market Segmentation

7. Contrast Media Injectors Market Regional And Country Analysis

8. Asia-Pacific Contrast Media Injectors Market

9. China Contrast Media Injectors Market

10. India Contrast Media Injectors Market

11. Japan Contrast Media Injectors Market

12. Australia Contrast Media Injectors Market

13. Indonesia Contrast Media Injectors Market

14. South Korea Contrast Media Injectors Market

15. Western Europe Contrast Media Injectors Market

16. UK Contrast Media Injectors Market

17. Germany Contrast Media Injectors Market

18. France Contrast Media Injectors Market

19. Italy Contrast Media Injectors Market

20. Spain Contrast Media Injectors Market

21. Eastern Europe Contrast Media Injectors Market

22. Russia Contrast Media Injectors Market

23. North America Contrast Media Injectors Market

24. USA Contrast Media Injectors Market

25. Canada Contrast Media Injectors Market

26. South America Contrast Media Injectors Market

27. Brazil Contrast Media Injectors Market

28. Middle East Contrast Media Injectors Market

29. Africa Contrast Media Injectors Market

30. Contrast Media Injectors Market Competitive Landscape And Company Profiles

31. Contrast Media Injectors Market Other Major And Innovative Companies

32. Global Contrast Media Injectors Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Contrast Media Injectors Market

34. Recent Developments In The Contrast Media Injectors Market

35. Contrast Media Injectors Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â